Strategic Vision 2026: Navigating the Global Fluorometholone Market
As of early 2026, the global fluorometholone market is experiencing a period of strategic recalibration. Valued at approximately $551 million this year, the market is projected to expand at a steady CAGR of 5.3%, reaching an estimated $750 million by 2033. While newer-generation steroids have entered the space, fluorometholone—a synthetic glucocorticoid derivative of desoxyprednisolone—remains a … Read more